Atlas Trials

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Clinical trial NCT02724254 · COMPLETED

Trial details

NCT number
NCT02724254
Sponsor
Vaxart
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Condyloma
Start date
2016-01-01
Primary completion
2018-05-01
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.